XTX Topco Ltd Buys 17,761 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

XTX Topco Ltd grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 354.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,778 shares of the company's stock after acquiring an additional 17,761 shares during the period. XTX Topco Ltd's holdings in Prestige Consumer Healthcare were worth $1,958,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of PBH. Cerity Partners LLC increased its stake in Prestige Consumer Healthcare by 3.7% during the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock worth $315,000 after acquiring an additional 132 shares during the period. Franklin Resources Inc. lifted its stake in Prestige Consumer Healthcare by 0.7% in the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after purchasing an additional 150 shares during the last quarter. KBC Group NV grew its position in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after acquiring an additional 151 shares during the last quarter. CIBC Private Wealth Group LLC increased its stake in shares of Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after buying an additional 152 shares during the period. Finally, McIlrath & Eck LLC raised its stake in shares of Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after acquiring an additional 154 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE PBH traded down $0.22 during trading hours on Friday, reaching $73.73. 423,917 shares of the company were exchanged, compared to its average volume of 406,596. The stock has a market capitalization of $3.64 billion, a P/E ratio of 17.19, a P/E/G ratio of 2.21 and a beta of 0.43. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a 1 year low of $64.94 and a 1 year high of $90.04. The business's 50 day simple moving average is $80.65 and its 200-day simple moving average is $82.30.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. Prestige Consumer Healthcare's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.02 EPS. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

PBH has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has an average rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.